| 1 |
Oveili E, Vafaei S, Bazavar H, Eslami Y, Mamaghanizadeh E, Yasamineh S, Gholizadeh O. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases. Cell Commun Signal 2023;21:20. [PMID: 36690996 DOI: 10.1186/s12964-022-01017-9] [Reference Citation Analysis]
|
| 2 |
Hun M, Wen H, Han P, Vun T, Zhao M, He Q. Bibliometric analysis of scientific papers on extracellular vesicles in kidney disease published between 1999 and 2022. Front Cell Dev Biol 2022;10:1070516. [PMID: 36684427 DOI: 10.3389/fcell.2022.1070516] [Reference Citation Analysis]
|
| 3 |
Haghighitalab A, Dominici M, Matin MM, Shekari F, Ebrahimi Warkiani M, Lim R, Ahmadiankia N, Mirahmadi M, Bahrami AR, Bidkhori HR. Extracellular vesicles and their cells of origin: Open issues in autoimmune diseases. Front Immunol 2023;14:1090416. [PMID: 36969255 DOI: 10.3389/fimmu.2023.1090416] [Reference Citation Analysis]
|
| 4 |
Motallebnezhad M, Omraninava M, Esmaeili Gouvarchin Ghaleh H, Jonaidi-Jafari N, Hazrati A, Malekpour K, Bagheri Y, Izadi M, Ahmadi M. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19. Pathol Res Pract 2023;241:154280. [PMID: 36580795 DOI: 10.1016/j.prp.2022.154280] [Reference Citation Analysis]
|
| 5 |
Liu X, Wei Q, Lu L, Cui S, Ma K, Zhang W, Ma F, Li H, Fu X, Zhang C. Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. Front Immunol 2023;14:1094685. [PMID: 36860847 DOI: 10.3389/fimmu.2023.1094685] [Reference Citation Analysis]
|
| 6 |
Alberti G, Russo E, Corrao S, Anzalone R, Kruzliak P, Miceli V, Conaldi PG, Di Gaudio F, La Rocca G. Current Perspectives on Adult Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Features and Clinical Indications. Biomedicines 2022;10:2822. [DOI: 10.3390/biomedicines10112822] [Reference Citation Analysis]
|
| 7 |
Sun F, Sun Y, Wu F, Xu W, Qian H. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. Pharmaceutics 2022;14:2208. [DOI: 10.3390/pharmaceutics14102208] [Reference Citation Analysis]
|
| 8 |
Xu W, Liu X, Qu W, Wang X, Su H, Li W, Cheng Y. Exosomes derived from fibrinogen-like protein 1-overexpressing bone marrow-derived mesenchymal stem cells ameliorates rheumatoid arthritis. Bioengineered 2022;13:14545-61. [PMID: 36694465 DOI: 10.1080/21655979.2022.2090379] [Reference Citation Analysis]
|
